Zelluna Immunotherapy announces investment from Takeda Ventures, Inc.
Zelluna Immunotherapy, a company focused on allogenic T-cell Receptor Natural Killer (TCR-NK) cells to treat…
Keep yourself up to date with the latest cell therapy news, including stem cell therapy, CAR-T cell therapy, and more. This section covers the latest updates on regulations, deals, and technology advancements of cell therapy companies.
Zelluna Immunotherapy, a company focused on allogenic T-cell Receptor Natural Killer (TCR-NK) cells to treat…
Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international…
During drug development, biologics often fail to transition from the preclinical to the clinical stage,…
A South Korean biotech company says it will use natural killer (NK) cells, exosomes and…
Three entities have joined forces to develop allogenic immune cell therapies based on a platform…
RoslinCT, a cell and gene therapy contract development and manufacturing organization (CDMO) developing life-changing therapies…
Enrollment has been completed for a study of a regenerative cell therapy investigational product for…
A clinical hold has been lifted by the US Food and Drug Administration (FDA) on…
AlloVir, Inc., a late clinical-stage allogeneic T-cell immunotherapy company, has entered into a securities purchase…
Oxford Biomedica plc, a UK-based gene and cell therapy group, has initiated a new project…
On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach,…
A company developing precision T cell therapies that treat solid tumors announced yesterday (July 21)…